Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
1.
Braz J Otorhinolaryngol ; 79(2): 185-9, 2013.
Article in English, Portuguese | MEDLINE | ID: mdl-23670324

ABSTRACT

UNLABELLED: The aim of this study is to analyze the success of extraoral osseointegrated implants used to support designed to rehabilitate craniofacial deformities. METHOD: This study was based on the retrospective assessment of charts from 59 patients submitted to cancer surgery and who received 164 extraoral implants to contain facial prosthesis. RESULTS: Among 164 implants, 42 were fixed in previously irradiated regions. Eight of the implants did not have osseointegration; and from these, two were fixed in irradiated bone. The result show 116 (95.1%) successfully osseointegrated implants in non-irradiated sites. The success rate among 42 implants fixed in previously irradiated bones was 40 (95.3%) osseointegrated implants. CONCLUSION: The use of extraoral craniofacial implants represents a safe and effective approach to treat facial deformities as a support for the rehabilitation prosthesis. Radiotherapy treatment does not prevent osseointegration.


Subject(s)
Facial Bones/radiation effects , Osseointegration/radiation effects , Prosthesis Implantation , Skull Neoplasms/surgery , Cranial Irradiation , Female , Humans , Male , Prosthesis Design , Prosthesis Retention , Skull Neoplasms/radiotherapy , Treatment Outcome
2.
Braz. j. otorhinolaryngol. (Impr.) ; Braz. j. otorhinolaryngol. (Impr.);79(2): 185-189, mar.-abr. 2013. ilus, tab
Article in Portuguese | LILACS | ID: lil-673225

ABSTRACT

O objetivo deste trabalho foi avaliar o resultado da osseointegração de implantes extraorais lemento de suporte e retenção de próteses nas reabilitações de deformidades faciais. MÉTODO: Estudo retrospectivo de prontuários de 59 indivíduos operados de câncer, submetidos a 164 implantes para retenção de prótese facial. RESULTADOS: Dos 59 indivíduos, 14 foram previamente irradiados e receberam 42 implantes. Quarenta e cinco indivíduos não foram irradiados e receberam 122 implantes. Do total de 164 implantes, oito não osseointegraram, dos quais dois foram instalados em osso previamente irradiados. O resultado representou o sucesso de 116 (95,1%) implantes osseointegrados nos indivíduos não irradiados. E sucesso de 40 (95,3%) implantes osseointegrados em ossos irradiados. CONCLUSÃO: Concluiu-se que o uso de implantes extraorais é uma técnica segura e eficaz como suporte e retenção para próteses faciais em indivíduos com deformidades nessa região. A radioterapia não impede a osseointegração.


The aim of this study is to analyze the success of extraoral osseointegrated implants used to support designed to rehabilitate craniofacial deformities. METHOD: This study was based on the retrospective assessment of charts from 59 patients submitted to cancer surgery and who received 164 extraoral implants to contain facial prosthesis. RESULTS: Among 164 implants, 42 were fixed in previously irradiated regions. Eight of the implants did not have osseointegration; and from these, two were fixed in irradiated bone. The result show 116 (95.1%) successfully osseointegrated implants in non-irradiated sites. The success rate among 42 implants fixed in previously irradiated bones was 40 (95.3%) osseointegrated implants. CONCLUSION: The use of extraoral craniofacial implants represents a safe and effective approach to treat facial deformities as a support for the rehabilitation prosthesis. Radiotherapy treatment does not prevent osseointegration.


Subject(s)
Female , Humans , Male , Facial Bones/radiation effects , Osseointegration/radiation effects , Prosthesis Implantation , Skull Neoplasms/surgery , Cranial Irradiation , Prosthesis Design , Prosthesis Retention , Skull Neoplasms/radiotherapy , Treatment Outcome
3.
Clin Transl Oncol ; 8(1): 39-44, 2006 Jan.
Article in English | MEDLINE | ID: mdl-16632438

ABSTRACT

INTRODUCTION: Retinoblastoma (RB) is the most frequent malignant eye tumor in childhood. In developing countries advanced stages are common. The purpose of this paper is to present our 21-year clinical experience with metastatic extra ocular RB patients treated with 5 different chemotherapy schemas at a single Mexican Pediatric referral center. MATERIALS AND METHODS: A retrospective analysis was carried out reviewing the clinical characteristics of patients with metastatic RB. The information analyzed included the delay in diagnosis after first symptoms, age, sex, ocular staging, and anatomic site of metastases, treatment scheme, initial response and status at the last contact or date of death. RESULTS: Eighty-one patients were included; age range was from 3 to 80 months. The most common site of metastasis was central nervous system (83.9%). From those patients treated with chemotherapy (n = 74), 89.2% presented a complete initial response (n = 66). Early mortality occurred in 7 cases before any treatment. Fifty-six received treatment and died with progressive disease. All patients without radiotherapy died with tumor activity (n = 15). The use of cisplatin was related with longer disease free intervals; no other variable was related with survival. Four patients were alive and disease free at 33 to 144.3 months of follow up from diagnosis. The prevalent cause of death was tumor progression. CONCLUSIONS: In our experience, metastatic RB has a very high mortality rate in spite of the use of different chemotherapy regimens.


Subject(s)
Eye Neoplasms/mortality , Retinoblastoma/secondary , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Bone Neoplasms/drug therapy , Bone Neoplasms/mortality , Bone Neoplasms/radiotherapy , Bone Neoplasms/secondary , Central Nervous System Neoplasms/drug therapy , Central Nervous System Neoplasms/mortality , Central Nervous System Neoplasms/radiotherapy , Central Nervous System Neoplasms/secondary , Child , Child, Preschool , Cisplatin/administration & dosage , Cobalt Radioisotopes/therapeutic use , Combined Modality Therapy , Cranial Irradiation , Disease Progression , Disease-Free Survival , Eye Neoplasms/drug therapy , Eye Neoplasms/pathology , Eye Neoplasms/radiotherapy , Eye Neoplasms/surgery , Female , Follow-Up Studies , Humans , Infant , Life Tables , Liver Neoplasms/drug therapy , Liver Neoplasms/mortality , Liver Neoplasms/secondary , Male , Mexico/epidemiology , Neoadjuvant Therapy , Proportional Hazards Models , Remission Induction , Retinoblastoma/drug therapy , Retinoblastoma/mortality , Retinoblastoma/pathology , Retinoblastoma/radiotherapy , Retinoblastoma/surgery , Retrospective Studies , Skull Neoplasms/drug therapy , Skull Neoplasms/mortality , Skull Neoplasms/radiotherapy , Skull Neoplasms/secondary , Survival Analysis , Treatment Outcome
4.
Braz J Otorhinolaryngol ; 71(6): 752-7, 2005.
Article in English | MEDLINE | ID: mdl-16878244

ABSTRACT

UNLABELLED: The treatment of glomic tumors has been controversial since its first description. It can be done with surgery, radiotherapy or just expectation. AIM: The objective of this paper was to evaluate the effectiveness and complications of radiotherapy. STUDY DESIGN: clinical with transversal cohort. MATERIAL AND METHOD: It was made a retrospective review in the charts of the patients with glomus jugulare tumors treated with radiotherapy. Disease control was determined by (1) no progression of symptoms or cranial nerve dysfunction or (2) no progression of the lesion in radiological follow-up. It was also evaluated the follow-up period and the sequelae of the treatment. RESULTS: Twelve patients were included, 8 of then women. The follow-up period was from 3 to 35 years, with a media of 11,6 years. The main symptoms were: hearing loss, pulsate tinnitus, dizziness and vertigo. The signs were pulsate retrotympanic mass, facial palsy and cofosis. The tumors were staged using Fisch's classification. The radiotherapy was performed with linear accelerator with dose ranging from 4500-5500 in 4-6 weeks. In the follow-up period were possible to identify sequelaes like dermatitis, meatal stenosis, cofosis and facial palsy. DISCUSSION: The signs and symptoms were the same found in the medical literature. The type and dosages of the radiotherapy were also the same of others reports. All patients had improvement of the symptoms and only one was not considered as having disease controlled. Complications were, in general, minor complications, with exception of the cofosis and facial palsy. CONCLUSION: Radiotherapy is a viable alternative to treatment of these tumors because their good response and low level of complications. It should be considered specially in advanced tumors where a surgical procedure could bring a high level of morbidity.


Subject(s)
Glomus Jugulare Tumor/radiotherapy , Skull Neoplasms/radiotherapy , Temporal Bone , Adult , Aged , Aged, 80 and over , Cohort Studies , Cross-Sectional Studies , Female , Follow-Up Studies , Humans , Male , Middle Aged , Radiotherapy Dosage , Tomography, X-Ray Computed , Treatment Outcome
5.
Acta pediátr. Méx ; 16(5): 197-200, sept.-oct. 1995. ilus
Article in Spanish | LILACS | ID: lil-173808

ABSTRACT

Se presenta el caso clínico de un paciente masculino de nueve años de edad con un año de evolución caracterizado por dolor intenso, hemifacila derecho, ataque al estado general, caracterizado por astenia, adinamia e hipodrexia, parálisis facial periférica izquierda y aumento de volumen cervical. La tomografía computada(TC), mostró tumoración que involucra la silla turca, seno cavernoso y fosa infratemporal derecha así como nasofaringe. El estudio histopatológico demostró ser carcinoma de nasofaringe. Se presenta el caso, se revisa la literatura y la casuística del Instituto Nacional de Pediatría de 1984 a 1994


Subject(s)
Child , Humans , Male , Alcoholism/complications , Doxorubicin/administration & dosage , Gastrostomy/statistics & numerical data , Head and Neck Neoplasms/etiology , Nasopharyngeal Neoplasms/diagnosis , Nasopharyngeal Neoplasms/drug therapy , Radiation Effects , Radiotherapy/statistics & numerical data , Skull Neoplasms/radiotherapy , Smoking/adverse effects , Tomography, Emission-Computed , Xerostomia/etiology
6.
J Craniofac Surg ; 5(4): 254-6, 1994 Sep.
Article in English | MEDLINE | ID: mdl-7833400

ABSTRACT

We report a craniofacial approach for resection of a giant-cell tumor of the sphenoid bone. Complementary radiotherapy was performed because of the incomplete tumor remotion. Four-year follow-up is presented.


Subject(s)
Giant Cell Tumor of Bone/surgery , Skull Neoplasms/surgery , Sphenoid Bone/surgery , Adolescent , Ethmoid Bone/surgery , Female , Giant Cell Tumor of Bone/radiotherapy , Humans , Neoplasm, Residual/radiotherapy , Orbit/surgery , Radiotherapy, Adjuvant , Skull Neoplasms/radiotherapy
7.
Arq Neuropsiquiatr ; 35(4): 307-17, 1977 Dec.
Article in Portuguese | MEDLINE | ID: mdl-588084

ABSTRACT

A series of 26 cases of hemangioma of the skull and review the literature are reported. The frontal localization was most frequent, contrary to the data of the literature suggesting the predominance of the parietal localization. The reported predominance of females has not been confirmed. In the present series the relation of males to females was 17:9. The radiological findings and treatment of hemangiomas are discussed. Direct puncture and injection of contrast medium is the best method for the visualization of the tumor. Treatment should be surgical consisting of total extirpation of the tumor with a margin of the healthy tissues. Direct extirpation is indicated only when soft-tissues are involved and there is no bone lesion. The en-bloque method is the technique of choice.


Subject(s)
Hemangioma, Cavernous/diagnostic imaging , Skull Neoplasms/diagnostic imaging , Adolescent , Adult , Child , Child, Preschool , Female , Hemangioma, Cavernous/radiotherapy , Hemangioma, Cavernous/surgery , Humans , Infant , Male , Radiography , Skull Neoplasms/radiotherapy , Skull Neoplasms/surgery
SELECTION OF CITATIONS
SEARCH DETAIL